3.09 -0.02(-0.64%)10/17/2024
OncoCyte Corp (OCX)
OncoCyte Corp (OCX)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
Headline | Time (ET) | Source |
---|---|---|
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles | 10/16 16:16 | prismmediawire.com |
Oncocyte Announces Participation in the LD Micro Main Event XVIIÂ Conference in Los Angeles | 10/16 16:15 | globenewswire.com |
Insider Buying Slows, but Not for 7 These Buyers | 10/13 09:45 | 247wallst.com |
Oncocyte's DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial | 10/08 08:31 | prismmediawire.com |
Oncocyte Signs Leading Transplant Centers in US and Germany | 10/02 19:13 | prismmediawire.com |
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules | 10/02 19:12 | prismmediawire.com |
Oncocyte's VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study | 08/12 16:30 | prismmediawire.com |